phenol and bms-986094
phenol has been researched along with bms-986094 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Amblard, F; Amiralaei, S; Bassit, L; Bobeck, D; Cho, JH; Coats, SJ; Detorio, M; Ehteshami, M; McBrayer, TR; Pradere, U; Schinazi, RF; Tao, S; Whitaker, T; Zhang, HW; Zhou, L | 1 |
| Bansal, S; Bao, H; Bourne, N; Chang, W; Du, J; Espiritu, C; Furman, PA; Keilman, M; Lam, AM; Micolochick Steuer, H; Murakami, E; Niu, C; Otto, MJ; Ross, BS; Sofia, MJ; Tolstykh, T; Veselenak, RL; Zennou, V | 1 |
Other Studies
2 other study(ies) available for phenol and bms-986094
| Article | Year |
|---|---|
β-D-2'-C-Methyl-2,6-diaminopurine Ribonucleoside Phosphoramidates are Potent and Selective Inhibitors of Hepatitis C Virus (HCV) and Are Bioconverted Intracellularly to Bioactive 2,6-Diaminopurine and Guanosine 5'-Triphosphate Forms.
Topics: 2-Aminopurine; Amides; Antiviral Agents; Cell Line; Cells, Cultured; Guanosine Triphosphate; Hepacivirus; Hepatitis C; Humans; Methylation; Phosphoric Acids; Prodrugs; Ribonucleosides | 2015 |
Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661.
Topics: Antiviral Agents; Biotransformation; Cathepsin A; Chromatography, High Pressure Liquid; Cloning, Molecular; Drug Evaluation, Preclinical; Guanosine Monophosphate; Guanylate Kinases; Hep G2 Cells; Hepacivirus; Hepatocytes; Humans; Lactic Acid; Luciferases; Microbial Sensitivity Tests; Mitochondria; Mutation; Nerve Tissue Proteins; Phenol; Phosphorylation; Prodrugs; Replicon; Viral Nonstructural Proteins; Virus Replication | 2011 |